RetaMaps

Medical Health Solutions

Medical Health Solutions · 8683 Lincoln Avenue · Lone Tree, CO 80124

4.9· 66 Google reviews

Listing updated October 2, 2026

Retatrutide outlook for this practice

No current plans confirmed — RetaMaps has not yet confirmed this practice's intentions regarding retatrutide. Inclusion on RetaMaps does not mean the provider offers or will offer retatrutide.

About this practice

Medical Health Solutions is a doctor-supervised medical weight-loss clinic in Lone Tree, Colorado. Per its website, services include medical weight loss, vitamin injections and men's health, and the program uses a protein-based approach with community support. The site lists Arie Blitz, MD, and references board certification in general surgery, cardiothoracic surgery and obesity medicine. On Google the clinic has a 4.9-star rating across 66 reviews since 2023, 33 of them in the past year. Reviewers most often mention the staff and results, and ten mention scheduling.

Services & access

Advertises semaglutide todayNot listed
Advertises tirzepatide todayNot listed
Telehealth visitsNot listed
Cash pay accepted—
Accepts insurance — per practice websiteYes
Accepting new patients — per practice websiteYes

"Not listed" means we didn't find this stated on the practice's public pages — it doesn't mean no. — means unknown. Medication rows describe currently FDA-approved GLP-1 medications the practice advertises today, not retatrutide. Confirm details directly with the practice.

Review activity

★ 4.9
Google rating · 66 reviews
33
reviews in the past year (avg ★ 4.9)
2
reviews mention GLP-1 medications
16
reviews mention weight loss

Counts computed by RetaMaps from public Google reviews; most recent review 2026-09-04. Read the reviews themselves on the practice's Google listing.

What patients say

Rated ★4.9 across 66 Google reviews. Of the 66 reviews we analyzed, 64 (97%) are positive (4–5★) and 2 (3%) are negative (1–2★).

What patients like

  • Friendly, helpful staff26 reviews
  • Weight-loss results21 reviews
  • Knowledgeable, professional providers16 reviews
  • Easy scheduling and communication10 reviews

Common complaints

Very few complaints — only 2 negative reviews, with no recurring theme.

5★
63
4★
1
3★
0
2★
0
1★
2

Most recent Google reviews

Megan W.★★★★★2026-09-04

My husband and I came in to see Tracy for a B12 injection and Botox and she took such great care of us! I highly recommend her to everyone! 5 star experience! Thanks Tracy!

Hannah S.★★★★★2026-08-28

Alexa is the absolute best!!! Highly recommend!! Process simple easy and the staff is great!

Jessica E.★★★★★2026-08-21

Everyone here is so nice, helpful, and very knowledgeable! I received a clear path on Botox from Tracy Lutrell who was amazing and from Gianni who went over a fantastic weight loss program for me an my husband. Thank you all so much

Darla H.★★★★★2026-07-20

Health Solutions in Lone Tree is amazing. I have been a client for close to two years. The staff, especially Adamaris, have always been professional, supporting, and engaged in my weight loss journey. They are very skilled, knowledgeable and answer all my questions. If I have a question that requires contacting the owner the feedback is fast and thorough. I am happy I found Health Solutions to go through my weight loss journey. I am grateful to Adamaris for her continued upbeat, positive, and wonderful support. Thank you.

Brink★★★★★2026-06-27

The staff is very friendly and helpful! They answered all of the questions I had.

Analysis by RetaMaps of reviews on this practice's public Google Business listing; review themes are detected automatically and reviews reflect their authors' opinions. See all reviews on Google.

Retatrutide status
Phase 3 complete · Not FDA-approvedUpdated October 2, 2026

Retatrutide is Eli Lilly's investigational once-weekly triple agonist (GIP, GLP-1 and glucagon receptors). Five Phase 3 trials have reported positive results, and Lilly plans to submit it to the FDA in Q1 2027. It is not FDA-approved, has no brand name or price, and cannot be prescribed outside clinical trials or Lilly's physician-requested expanded access program. Products sold online as "research" or compounded retatrutide are not legitimate retatrutide.

Development
Phase 3 complete
FDA status
Submission planned — Q1 2027 (Lilly guidance)
Availability
Not commercially available
Access routes
Clinical trials, or Lilly's expanded access program (physician must apply)

Next milestone: TRIUMPH-5 head-to-head vs tirzepatide results (Expected ~Dec 2026)

Sources: Lilly — What to know about retatrutide · Lilly — TRIUMPH-2/TRIUMPH-3 results · BioPharma Dive — FDA submission plans · STAT — Lilly expanded access (Aug 3, 2026) · FDA — Concerns with unapproved GLP-1 drugs